...
首页> 外文期刊>Journal of Hepatology: The Journal of the European Association for the Study of the Liver >Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites
【24h】

Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites

机译:肝硬化和顽固性腹水患者中严重低钠血症比MELDNa更好地预测死亡率

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background & Aims: The MELDNa score was developed to improve the prognostic value of the MELD score in cirrhosis and was built for serum sodium concentrations numerically capped between 125 and 140 mmol/L. This model is not validated in a well-defined population of patients with cirrhosis and refractory ascites in whom severe hyponatremia (≤125 mmol/L) is frequent. This study assessed the prognostic value of severe hyponatremia and the MELDNa score in these patients. Methods: A consecutive, single-centre, observational, prospective study was performed in patients with cirrhosis and refractory ascites defined according to the International Ascites Club criteria. The prevalence of low serum sodium was assessed in this population. Predictive factors of mortality were analyzed and compared. Results: One hundred seventy-four patients were included. Sixty-six (37.9%) had low serum sodium (<130 mmol/L). Sixty-one (35.1%) had diuretic-intractable ascites due to severe hyponatremia (≤125 mmol/L). The median MELDNa score was 23 (10-33). The 1-year cumulative incidence of death was 55% (95% CI: 55-56%). The best predictive factors of mortality were the following: severe hyponatremia (≤125 mmol/L) as an underlying cause of refractory ascites, a higher Child-Pugh score, beta-blocker therapy, and a high frequency of large-volume paracentesis. The Child-Pugh score had a higher area under receiver operating curve to predict mortality than MELDNa. Conclusions: In patients with cirrhosis and refractory ascites, severe hyponatremia and Child-Pugh score are better predictors of mortality than MELDNa.
机译:背景与目的:MELDNa评分旨在改善MELD评分在肝硬化中的预后价值,并建立在数值介于125至140 mmol / L之间的血清钠浓度的基础上。在明确定义的肝硬化和顽固性腹水患者人群中,该人群的严重低钠血症(≤125mmol / L)频繁发生,该模型尚未得到验证。这项研究评估了严重低钠血症和MELDNa评分在这些患者中的预后价值。方法:对根据国际腹水俱乐部标准定义的肝硬化和难治性腹水患者进行了连续,单中心,观察性和前瞻性研究。在该人群中评估了低血清钠的患病率。分析和比较了死亡率的预测因素。结果:纳入174例患者。六十六(37.9%)的血清钠含量低(<130 mmol / L)。严重低钠血症(≤125mmol / L)有61名(35.1%)具有利尿剂顽固性腹水。 MELDNa评分中位数为23(10-33)。 1年累计死亡发生率为55%(95%CI:55-56%)。死亡率的最佳预测因素如下:严重低钠血症(≤125mmol / L)是顽固性腹水的根本原因,Child-Pugh评分较高,β受体阻滞剂治疗以及大容量穿刺术的发生频率较高。与MELDNa相比,Child-Pugh评分在接受者操作曲线下具有更高的区域来预测死亡率。结论:在肝硬化和顽固性腹水患者中,严重低钠血症和Child-Pugh评分比MELDNa更好地预测死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号